Pfizer Inc
Moderna’s combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Empty bottles of Moderna’s Covid-19 vaccine. Fred Tanneau | AFP | Getty Images Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial. The biotech company is the first to release positive phase three data on a […]
Read More
FDA approves GSK’s RSV vaccine for high-risk adults ages 50 to 59, expanding shot’s reach
A view shows GlaxoSmithKline headquarters in London, Britain, January 17, 2022. Hannah Mckay | Reuters The Food and Drug Administration on Friday expanded the approval of GSK‘s respiratory syncytial virus vaccine to adults ages 50 to 59 who are at increased risk of getting severely sick from the potentially lethal virus. The shot, called Arexvy, […]
Read More
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! I’m back in New York City after spending the last weekend in […]
Read More
FDA approves Moderna’s RSV vaccine for seniors, the company’s second-ever product
The FDA has approved Moderna’s RSV vaccine for older adults. Courtesy: Moderna The Food and Drug Administration on Friday approved Moderna’s vaccine for respiratory syncytial virus for adults ages 60 and above, the company’s second-ever product to enter the U.S. market. The decision is a win for Moderna, which desperately needs another revenue source amid […]
Read More
Pfizer’s drug for advanced lung cancer shows promising long-term trial results
CHICAGO — Pfizer on Friday said its drug for an advanced form of lung cancer showed promising long-term results in a late-stage trial, which may help establish it as the new standard treatment for the condition. The company’s medicine helped patients live longer without seeing their cancer progress, and most people experienced that benefit for […]
Read More
Healthy Returns: Pfizer, Merck, J&J and more to release cancer drug data at industry conference
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika, and I’ll be on the ground at the American […]
Read More
Here’s how U.S. health officials are responding to bird flu in humans after second case
Cows are seen standing in a feedlot on June 14, 2023 in Quemado, Texas. Brandon Bell | Getty Images U.S. health officials are monitoring and preparing to combat bird flu in humans, even as they stress that the risk to the general public remains low. A strain of bird flu called H5N1 has been confirmed […]
Read More
Pfizer aims to save $1.5 billion by 2027 in first wave of new cost cuts
Exterior view of the Pfizer headquarters building on January 29, 2023 in New York City. Kena Betancur | Corbis News | Getty Images Pfizer on Wednesday said it has launched a new multi-year program to reduce costs as it works to rebound from the rapid decline of its Covid business. The announcement is in addition […]
Read More
AstraZeneca targets $80 billion in total revenue by 2030 in ‘post-Covid era’
The Astrazeneca logo is pictured at the World Artificial Intelligence Conference 2021 in Shanghai, China, July 7, 2021. Costfoto | Future Publishing | Getty Images LONDON — Pharmaceutical company AstraZeneca on Tuesday said it planned to increase its total revenue to $80 billion by 2030 — up 75% from $45.8 billion in 2023. “We have […]
Read More
Novavax stock jumps 50% as Sanofi offer kicks off turning issue for battling vaccine maker
A vial labelled “Novavax V COVID-19 Vaccine” is witnessed in this illustration taken January 16, 2022. Dado Ruvic | Reuters Shares of Novavax jumped as a lot as 50% on Monday as Wall Road cheered the firm’s new multibillion-dollar offer with French drugmaker Sanofi that sparked a spectacular turnaround for the having difficulties vaccine maker. […]
Read More